PofoliaShared via Pofolia

Archives of Osteoporosis· 2013Q2

Osteoporosis in the European Union: a compendium of country-specific reports

the EU review panel of the IOF, A Svedbom, E Hernlund, M Ivergård et al.

Short summary

Osteoporosis affected 22 million women and 5.5 million men in the EU in 2010, leading to 3.5 million fractures and a €37 billion economic burden, with costs projected to rise 25% by 2025.

AI-generated from the title and abstract; the full text is not read.

Key points

  • In 2010, 22 million women and 5.5 million men in the EU had osteoporosis.
  • 3.5 million fragility fractures occurred in the EU in 2010, costing €37 billion.
  • Osteoporosis-related costs are projected to increase by 25% by 2025.
  • The majority of individuals with osteoporosis or at high risk remain untreated.
  • The number of patients receiving osteoporosis treatment has been declining.

AI-generated from the title and abstract; the full text is not read.

Abstract

UNLABELLED: This report describes epidemiology, burden, and treatment of osteoporosis in each of the 27 countries of the European Union (EU27). INTRODUCTION: In 2010, 22 million women and 5.5 million men were estimated to have osteoporosis in the EU; and 3.5 million new fragility fractures were sustained, comprising 620,000 hip fractures, 520,000 vertebral fractures, 560,000 forearm fractures and 1,800,000 other fractures. The economic burden of incident and prior fragility fractures was estimated at € 37 billion. Previous and incident fractures also accounted for 1,180,000 quality-adjusted life years lost during 2010. The costs are expected to increase by 25 % in 2025. The majority of individuals who have sustained an osteoporosis-related fracture or who are at high risk of fracture are untreated and the number of patients on treatment is declining. The aim of this report was to characterize the burden of osteoporosis in each of the EU27 countries in 2010 and beyond. METHODS: The data on fracture incidence and costs of fractures in the EU27 were taken from a concurrent publication in this journal (Osteoporosis in the European Union: Medical Management, Epidemiology and Economic Burden) and country specific information extracted. RESULTS: The clinical and economic burden of osteoporotic fractures in 2010 is given for each of the 27 countries of the EU. The costs are expected to increase on average by 25 % in 2025. The majority of individuals who have sustained an osteoporosis-related fracture or who are at high risk of fracture are untreated and the number of patients on treatment is declining. CONCLUSIONS: In spite of the high cost of osteoporosis, a substantial treatment gap and projected increase of the economic burden driven by aging populations, the use of pharmacological prevention of osteoporosis has decreased in recent years, suggesting that a change in healthcare policy concerning the disease is warranted.

The authors' abstract, as published at the source. Archives of Osteoporosis, 2013 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Orthopedics and Sports Medicine

Orthopedics and Sports MedicineMedicine